Nanotechnology In China Research Articles

Nanotechnology development in China: challenges and opportunities

Abstract China has invested heavily in nanotechnology in the past decades. It's one of the key areas of focus in the medium and long-term scientific programmes between 2006 and 2020. In 2012, the country also launched a Strategic Pioneering Programme on nanotechnology, which has a budget of one billion yuan (US$152 million) over five years and is led by the Chinese Academy of Sciences (CAS) in Beijing. As a result of this long-term investment, China is now a major player in nanotechnology, ranking first worldwide in terms of the number of scientific papers and patents. At the Sixth International Conference on Nanoscience and Technology—which was held in Beijing on 3–5 September, 2015—Chunli Bai, President of CAS and Editor-in-Chief of National Science Review (NSR), shared a platform with another five leading scientists, where they discussed recent progress of nanotechnology in China, the potential impact of nanoparticles on public health, as well as challenges and opportunities ahead. Chunli Bai (Chair) President of Chinese Academy of Sciences in Beijing Minghua Liu An expert on nano materials and molecular assembly and Director of National Center for Nanoscience and Technology, China, in Beijing Zhongfan Liu An expert on nanochemistry and graphene at Peking University Chen Wang An expert on nanomicroscopy and nanomedicine and Deputy Director of National Center for Nanoscience and Technology, China, in Beijing Peidong Yang An expert on nanomaterials and their application in energy research at the University of California at Berkeley, USA Yuliang Zhao An expert on nanomedicine and nanosafety at National Center for Nanoscience and Technology, China, and Chinese Academy of Sciences’ Institute of High Energy Physics

High support for nanotechnology in China: A case study in Dalian

Public perception of nanotechnology is important as it helps scientists and policy makers understand how the public decides whether or not to support the development of these technologies. To examine the public’s perception and attitude toward nanotechnology in China, we conducted a case study in Dalian through a survey in 2013 (N = 741). Support for the technology was indicated by 96.6% of the sample. This sample also had the highest self-reported awareness of nanotechnology worldwide, with 88.4% of the sample reporting having heard of nanotechnology, although they possessed little knowledge about the technology. Support was associated more with beliefs (e.g. expectations for nanotechnology, trust, benefit/risk ratio) than with knowledge. Mass media news reports and advertisements were the top means of communication about nanotechnology. It is very possible that the rate of support for nanotechnology may change in future, as with support for genetically modified food.

我国纳米科学技术发展现状及战略思考

This article outlines recent advances in the fields of nanoscience and nanotechnology in China and highlights representative research outcomes of Chinese researchers in the last decade. The author also summarizes the trend of research into nanotechnology worldwide and analyze restrictive factors (and their origins) leading to bottlenecks in the development of nanotechnology in China. The interactions of the following issues may be the main factors restricting the sustainable development of nanotechnology in China: total investment in nanotechnology is relatively low (insufficient), the levels of development in the different subtopics of nanotechnology fields are disproportion, there remains a lack of efficient pathways among innovation chains, no strategic framework has been well established, the research outcomes of original innovation are still few, and the standardization of industrial nanotechnology is lagging. The author also discusses the strategy of nanotechnology development in terms of how to implement the strategy of innovation development, boost independent innovation, encourage cross-disciplinary research, build efficient collaborations among industry- academy-educations, foster nano-industrial sectors, and strengthen international collaborations.

Macromolecular self-assembly and nanotechnology in China

Macromolecular self-assembly refers to the assembly of synthetic polymers, biomacromolecules and supra-molecular polymers. Through macromolecular self-assembly, the fabrication of ordered structures at different scales, the control of the dynamic assembly process and the integrations of advanced functions can be realized. Macromolecular self-assembly and nanotechnology research in China has developed rapidly, from the early periods of follow-up at low to high level and progress into a stage of innovation and creation. This review selects some representative progresses achieved recently, aiming to reflect the current status of macromolecular self-assembly and nanotechnology research in China.

Progress of nanoscience in China

Fast evolving nanosciences and nanotechnology in China has made it one o f the front countries of nanotechnology development. In this review, we summarize some most recent progresses in nanoscience research and nanotechnology development in China. The topics we selected in this article include nano-fabrication, nanocatalysis, bioinspired nanotechnology, green printing nanotechnology, nanoplasmonics, nanomedicine, nanomaterials and their applications, energy and environmental nanotechnology, nano EHS (nanosafety), etc. Most of them have great potentials in applications or application-related key issues in future.

“Research is high and the market is far away”: Commercialization of nanotechnology in China

As a country that has chosen nanotechnology as one of its priority investment areas to facilitate leapfrogging in science and technology, China has already seen a return on investment in the exponential rise of scientific papers originating in Chinese nanotechnology labs. There has also been an increasing number of patents filed by Chinese inventors as well as fierce competition among Chinese localities for a prime position in the twenty-first century nanotechnology revolution. Based on fieldwork in China and secondary research, this paper examines the commercialization of nanotechnology in China from the intertwined perspectives of academia–industry relations, government support and policy, role of venture capital, and international connections, while also taking into account the views of Chinese nanoscientists. The results show that despite tangible success in publishing, patenting, and the creation of dedicated nanotechnology science parks, China's effort to commercialize nanotechnology has been much slower than anticipated by nanoscientists and political leadership.

A Special Issue on Nanotechnology in China

<i>A Special Issue</i> on Nanotechnology in China

Developmental state and innovation: nanotechnology in China

AbstractIn this article we examine the role of the Chinese government in fostering advances in nanotechnology, while looking at the promises and pitfalls of state‐led development in the world's fastest‐growing major economy. China, like many countries involved in catch‐up development, is convinced that manufacturing prowess alone is not enough to make it a leading economic power in the twenty‐first century. Our concern here is how, within the context of nanotechnology, China's approach to national development reflects the debate on innovation. Many countries, including the United States, see government spending on nanotechnology as essential to creating world leadership in this emerging field. The USA, for example, expects to spend $1.8 billion in 2011 on its National Nanotechnology Initiative – primarily to foster basic research and development. Unlike the USA, government sources largely fund nanotechnology in China, for its economy is in transition from state‐owned to privately‐owned enterprises and still suffers from a lack of private investment capital. Moreover, in China, such funding extends more broadly across the value chain than in the United States, from fundamental research to commercialization. Through field research and extensive interviews, in this article we document and evaluate the effectiveness of China's state‐led efforts to become a global nanotech leader.

Research and Development of Nanopharmaceuticals in China

Nanopharmacoeuticals based on nanomaterials and nanotechnology are medicinal products for drug delivery, nano drugs and nano therapies, in vivo imaging, in vitro diagnostics, biomaterials, and active implants. Nanoscience and nanotechnology in China become ever more consequential in our lives, all members of the scientific community should better inform and educate the public about the great changes this new nano era is likely to bring. Here we review some main advances on the research and development of nanomaterials, nanotechnology and nanopharmaceuticals in China. For nanopharmaceuticals, we focus on the research and application of nanotechnology in anti-cancer drugs, and biological evaluation studies of nanomaterials.

From lab to market? Strategies and issues in the commercialization of nanotechnology in China

Nanotechnology is expected by many to be one of the next drivers of technology-based business and economic growth. China has emerged as a global player in nanotechnology development, and now ranks second (after the United States) in nanotechnology scientific publications produced annually. The study of nanotechnology offers a lens to examine China's capabilities to move closer to the frontier of technology-led economic development, explore the evolving Chinese innovation system, and assess the effectiveness of policy strategies to modernize and add-value to research and industry in China. Supported by new policy initiatives and funding, hundreds of institutions and thousands of researchers in China are engaged in nanotechnology R&D. Yet, although Chinese nanotechnology research has scale, the pathways from laboratory research to successful commercialization remain problematic. Chinese performance in nanotechnology patenting and product development is weak relative to its research strength, suggesting a significant gap between the research base and industrial development. Drawing on bibliometric research and field interviews with Chinese nanotechnology policymakers, researchers and business representatives, we analyze this gap, explore the factors contributing to it and assess future commercialization trajectories.

Tracking the Current Rise of Chinese Pharmaceutical Bionanotechnology

THE CONTEXT AND PURPOSE OF THE STUDY: Over the last decade China has emerged as a major producer of scientific publications, currently ranking second behind the US. During that time Chinese strategic policy initiatives have placed indigenous innovation at the heart of its economy while focusing internal R&D investments and the attraction of foreign investment in nanotechnology as one of their four top areas. China's scientific research publication and nanotechnology research publication production has reached a rank of second in the world, behind only the US. Despite these impressive gains, some scholars argue that the quality of Chinese nanotech research is inferior to US research quality due to lower overall times cited rates, suggesting that the US is still the world leader. We combine citation analysis, text mining, mapping, and data visualization to gauge the development and application of nanotechnology in China, particularly in biopharmananotechnology, and to measure the impact of Chinese policy on nanotechnology research production. Our text mining-based methods provide results that counter existing claims about Chinese nanotechnology research quality. Due in large part to its strategic innovation policy, China's output of nanotechnology publications is on pace to surpass US production in or around 2012.A closer look at Chinese nanotechnology research literature reveals a large increase in research activity in China's biopharmananotechnology research since the implementation in January, 2006 of China's Medium & Long Term Scientific and Technological Development Plan Guidelines for the period 2006-2020 ("MLP"). Since the implementation of the MLP, China has enjoyed a great deal of success producing bionano research findings while attracting a great deal of foreign investment from pharmaceutical corporations setting up advanced drug discovery operations. Given the combination of current scientific production growth as well as economic growth, a relatively low scientific capacity, and the ability of its policy to enhance such trends, China is in some sense already the new world leader in nanotechnology. Further, the Chinese national innovation system may be the new standard by which other national S&T policies should be measured.

Chinese Trends: Review of Food Nanotechnology in China

Chinese Trends: Review of Food Nanotechnology in China

Activities related to health, environmental and societal aspects of nanotechnology in China

Activities related to the health, environmental and societal (EHS) aspects of nanotechnology R&D programs in China are outlined. To create a really harmonious society, China's strategy for science and technology is to achieve sustainable development by implementing clean production of, in particular, nanoproducts. Funding organs in China encourage researchers to take timely and responsible advantage of the new technology for sustainable development, and to initiate studies on societal implications from the beginning of nanotechnology development. The annual governmental investment in health, environmental and societal is now about US$ 2.6 million. We are trying our best to make nanotechnology the first clean technology from which our life can benefit, while harm to human health and the environment is avoided.

Mistakes in a Map

The Essay “Ascent of Nanoscience in China” by C. Bai (1 July, p. [61][1]) is an articulate overview of the main achievements and progress of nanoscience and nanotechnology in China. On page 61, there is a map with a patch highlighted in orange. This is apparently meant to be a map of China, but there are several errors. Mongolia is highlighted, but it has been an independent country since 1921. Hainan and Taiwan are not highlighted on the map, but they are both provinces of China. I am quite surprised at finding these errors in Science . # Response {#article-title-2} The Editors apologize for including a map in which Mongolia is highlighted in such a way as to indicate that it is a part of China. As for the non-highlighting of the islands of Taiwan and Hainan, we assure readers that this does not indicate a Science policy on the Taiwan question. Science has no such policy. [1]: /lookup/doi/10.1126/science.1115172

Progress of Nanoscience and Nanotechnology in China

Nanoscience and nanotechnology has been attracting wide attention and is becoming an active frontier area. Chinese scientists have followed with the main stream interest in the development of Nanoscience and nanotechnology since its initial stage. In the present paper, the achievements and present status of China in relative researches such as nanomaterials, nanodevices and characterization of nanostructure are described.

Nanotechnology in China

Nanotechnology in China